Published in J Virol on December 01, 1997
Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. J Virol (1999) 4.84
Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J Virol (2000) 3.35
Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol (2005) 2.77
In silico pattern-based analysis of the human cytomegalovirus genome. J Virol (2003) 1.52
Reconstruction of the complete human cytomegalovirus genome in a BAC reveals RL13 to be a potent inhibitor of replication. J Clin Invest (2010) 1.50
High-throughput sequence analysis of variants of human cytomegalovirus strains Towne and AD169. J Gen Virol (2009) 1.34
Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Virology (1997) 1.32
Genomic sequence of rhesus cytomegalovirus 180.92: insights into the coding potential of rhesus cytomegalovirus. J Virol (2006) 1.31
Murine cytomegalovirus m41 open reading frame encodes a Golgi-localized antiapoptotic protein. J Virol (2003) 1.28
Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J Virol (2005) 1.16
Genomic and functional characteristics of human cytomegalovirus revealed by next-generation sequencing. Viruses (2014) 1.05
Human cytomegalovirus pUS24 is a virion protein that functions very early in the replication cycle. J Virol (2006) 1.02
Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling. J Virol (2006) 1.00
Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products. J Virol (2006) 0.98
In vitro and in vivo characterization of a murine cytomegalovirus with a transposon insertional mutation at open reading frame M43. J Virol (2000) 0.91
Self-boosting vaccines and their implications for herd immunity. Proc Natl Acad Sci U S A (2012) 0.81
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem (1983) 206.01
Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr Top Microbiol Immunol (1990) 16.31
Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol (1996) 6.64
Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol (1996) 5.44
The DNA sequence of human herpesvirus-6: structure, coding content, and genome evolution. Virology (1995) 4.77
Transactivation of the cytomegalovirus ICP36 gene promoter requires the alpha gene product TRS1 in addition to IE1 and IE2. J Virol (1992) 2.95
A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology (1993) 2.78
Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J Virol (1992) 2.72
Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII. J Virol (1982) 2.59
An immediate early gene of human cytomegalovirus encodes a potential membrane glycoprotein. Virology (1988) 2.59
Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol (1996) 2.37
Insertional mutagenesis of the murine cytomegalovirus genome: one prominent alpha gene (ie2) is dispensable for growth. Virology (1988) 2.17
Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome. J Gen Virol (1982) 2.05
Genes in the HindIII J fragment of the murine cytomegalovirus genome are dispensable for growth in cultured cells: insertion mutagenesis with a lacZ/gpt cassette. J Virol (1994) 1.98
Dramatic interstrain differences in the replication of human cytomegalovirus in SCID-hu mice. J Infect Dis (1995) 1.69
Human cytomegalovirus DNA: BamHI, EcoRI and PstI restriction endonuclease cleavage maps. Gene (1982) 1.29
Identification of homologues to the human cytomegalovirus US22 gene family in human herpesvirus 6. J Gen Virol (1992) 1.13
Identification and characterization of a human herpesvirus 6 gene segment that trans activates the human immunodeficiency virus type 1 promoter. J Virol (1992) 1.09
Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6. Virology (1994) 0.96
The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 19.25
Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1. J Mol Biol (1985) 7.32
On the predictive recognition of signal peptide sequences. Virus Res (1985) 5.21
Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis. J Virol (1988) 5.11
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae. J Virol (1996) 5.05
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the genes for DNA polymerase and the major DNA binding protein. Nucleic Acids Res (1985) 4.84
Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res (1986) 4.55
Characterization of the IE110 gene of herpes simplex virus type 1. J Gen Virol (1986) 4.19
Orientation of herpes simplex virus type 1 immediate early mRNA's. Nucleic Acids Res (1979) 3.54
The genome sequence of herpes simplex virus type 2. J Virol (1998) 3.39
DNA sequence analysis of an immediate-early gene region of the herpes simplex virus type 1 genome (map coordinates 0.950 to 0.978). J Gen Virol (1982) 3.16
Structures of herpes simplex virus type 1 genes required for replication of virus DNA. J Virol (1988) 2.97
The DNA of a minute virus of mice. J Gen Virol (1969) 2.93
Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol (1995) 2.84
Mouse p53 inhibits SV40 origin-dependent DNA replication. Nature (1987) 2.71
Analysis of the 3'-terminal nucleotide sequence of vesicular stomatitis virus N protein mRNA. Nucleic Acids Res (1978) 2.68
Polypeptides specified by the influenza virus genoma. 2. Assignement of protein coding functions to individual genome segments by in vitro translation. Virology (1977) 2.64
The DNA sequences of the long repeat region and adjoining parts of the long unique region in the genome of herpes simplex virus type 1. J Gen Virol (1988) 2.50
A C-terminal alpha-helix plus basic region motif is the major structural determinant of p53 tetramerization. Oncogene (1992) 2.41
Structure of the gene N:gene NS intercistronic junction in the genome of vesicular stomatitis virus. Cell (1979) 2.37
Characterisation of a herpes simplex virus type 1 mutant which has a temperature-sensitive defect in penetration of cells and assembly of capsids. Virology (1984) 2.35
The products of herpes simplex virus type 1 gene UL26 which are involved in DNA packaging are strongly associated with empty but not with full capsids. J Gen Virol (1988) 2.34
DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters. Nucleic Acids Res (1985) 2.33
DNA sequence and genetic content of the HindIII l region in the short unique component of the herpes simplex virus type 2 genome: identification of the gene encoding glycoprotein G, and evolutionary comparisons. J Gen Virol (1987) 2.32
Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J Gen Virol (1991) 2.21
Assembly of enveloped tegument structures (L particles) can occur independently of virion maturation in herpes simplex virus type 1-infected cells. J Gen Virol (1992) 2.18
Alphaherpesviruses possess a gene homologous to the protein kinase gene family of eukaryotes and retroviruses. Nucleic Acids Res (1986) 2.18
Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J Virol (2000) 2.17
A mutant of herpes simplex virus type 1 in which the UL13 protein kinase gene is disrupted. J Gen Virol (1993) 2.15
Identification of the herpes simplex virus protein kinase as the product of viral gene US3. J Gen Virol (1987) 2.06
Investigation of herpes simplex virus type 1 genes encoding multiply inserted membrane proteins. J Gen Virol (1991) 2.03
Parent reported home smoking bans and toddler (18-30 month) smoke exposure: a cross-sectional survey. Arch Dis Child (2005) 2.00
DNA sequence of the herpes simplex virus type 1 gene encoding glycoprotein gH, and identification of homologues in the genomes of varicella-zoster virus and Epstein-Barr virus. Nucleic Acids Res (1986) 1.99
Multiple interactions control the intracellular localization of the herpes simplex virus type 1 capsid proteins. J Gen Virol (1996) 1.96
The DNAs of three parvoviruses. J Gen Virol (1970) 1.96
Neurovirulence factor. Nature (1991) 1.95
The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J Gen Virol (1992) 1.84
Identification and mapping of two polypeptides encoded within the herpes simplex virus type 1 thymidine kinase gene sequences. J Virol (1981) 1.83
Identification of the gene encoding the 65-kilodalton DNA-binding protein of herpes simplex virus type 1. J Virol (1988) 1.81
A 3' co-terminal family of mRNAs from the herpes simplex virus type 1 short region: two overlapping reading frames encode unrelated polypeptide one of which has highly reiterated amino acid sequence. Nucleic Acids Res (1984) 1.78
Localization of the herpes simplex virus type 1 major capsid protein VP5 to the cell nucleus requires the abundant scaffolding protein VP22a. J Gen Virol (1994) 1.73
Gene UL11 of herpes simplex virus type 1 encodes a virion protein which is myristylated. J Gen Virol (1989) 1.70
Characterization of the UL10 gene product of herpes simplex virus type 1 and investigation of its role in vivo. J Gen Virol (1993) 1.64
Comparisons of nucleotide sequences in the genomes of the New Jersey and Indiana serotypes of vesicular stomatitis virus. J Virol (1980) 1.61
Microbial monitoring of the hospital environment: why and how? J Hosp Infect (2012) 1.60
p53 interacts with p34cdc2 in mammalian cells: implications for cell cycle control and oncogenesis. Oncogene (1990) 1.59
Evolutionary comparisons of the S segments in the genomes of herpes simplex virus type 1 and varicella-zoster virus. J Gen Virol (1986) 1.59
DNA sequence of the region in the genome of herpes simplex virus type 1 containing the exonuclease gene and neighbouring genes. Nucleic Acids Res (1986) 1.56
Mouse p53 blocks SV40 DNA replication in vitro and downregulates T antigen DNA helicase activity. Oncogene (1988) 1.53
HLA class I molecules are not transported to the cell surface in cells infected with herpes simplex virus types 1 and 2. J Immunol (1994) 1.53
Gene UL2 of herpes simplex virus type 1 encodes a uracil-DNA glycosylase. J Gen Virol (1989) 1.52
The 10K virion phosphoprotein encoded by gene US9 from herpes simplex virus type 1. Virology (1986) 1.50
Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells. Mol Cell Biol (1988) 1.48
Detailed analysis of the mRNAs mapping in the short unique region of herpes simplex virus type 1. Nucleic Acids Res (1985) 1.48
Determination of the sequence alteration in the DNA of the herpes simplex virus type 1 temperature-sensitive mutant ts K. J Gen Virol (1984) 1.47
The myristylated virion proteins of herpes simplex virus type 1: investigation of their role in the virus life cycle. J Gen Virol (1992) 1.47
Relationships and host range of human, canine, simian and porcine isolates of simian virus 5 (parainfluenza virus 5). J Gen Virol (2004) 1.46
Sequence of 200 nucleotides at the 3'-terminus of the genome RNA of vesicular stomatitis virus. Nucleic Acids Res (1979) 1.46
High functioning autism and Childhood Disintegrative Disorder in half brothers. J Autism Dev Disord (2000) 1.40
Natural science in Japan. I. Before 1830. Ann Sci (1973) 1.38
Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. Am J Hum Genet (1996) 1.38
Enhanced mutability associated with a temperature-sensitive mutant of vesicular stomatitis virus. J Virol (1981) 1.36
Characterization of herpes simplex virus type 2 transcription during latent infection of mouse trigeminal ganglia. J Virol (1990) 1.34
Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen. J Virol (1988) 1.24
Noninfectious L-particles supply functions which can facilitate infection by HSV-1. Virology (1992) 1.20
Botulinum toxin treatment of spasticity in diplegic cerebral palsy: a randomized, double-blind, placebo-controlled, dose-ranging study. Dev Med Child Neurol (2002) 1.17
Characterization of a monoclonal antibody (6G12) recognizing the cynomolgus monkey CD3 antigen. Transplant Proc (1994) 1.15
A novel herpes simplex virus gene (UL49A) encodes a putative membrane protein with counterparts in other herpesviruses. J Gen Virol (1992) 1.13
Ocular neuromyotonia. A clinical description of six patients. Arch Ophthalmol (1986) 1.12
Analysis of virion RNA segments and polypeptides of influenza A virus recombinants of defined virulence. Nature (1978) 1.09
Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. J Gen Virol (1986) 1.05
Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes. J Virol (2003) 1.05
Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17. J Gen Virol (1992) 1.04
Sequence analysis of the splice junction in the transcript of herpes simplex virus type 1 gene UL15. Virus Res (1991) 1.01
Nonketotic hyperglycinemia. Glycine accumulation due to absence of glycerine cleavage in brain. N Engl J Med (1975) 0.98
Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer? Curr Oncol (2012) 0.97
When are the hands of healthcare workers positive for methicillin-resistant Staphylococcus aureus? J Hosp Infect (2010) 0.95
Isolation and characterization of conditional lethal amber nonsense mutants of vesicular stomatitis virus. J Gen Virol (1987) 0.95
Pulmonary response to inhaled antigen: neuroimmune interactions promote the recruitment of dendritic cells to the lung and the cellular immune response to inhaled antigen. Am J Pathol (1997) 0.94
Self-medication for elderly patients. Nurs Times (1990) 0.93
Doublet frequency analysis of bacterial DNAs. J Mol Evol (1973) 0.92
Evolution of the dUTPase gene of mammalian and avian herpesviruses. Curr Protein Pept Sci (2001) 0.91
In vivo and in vitro hamster models in the assessment of virulence of recombinant influenza viruses. Antiviral Res (1983) 0.90
Genomic studies of the Lucké tumor herpesvirus (RaHV-1). J Cancer Res Clin Oncol (1999) 0.90